Equities research analysts expect Waters Co. (NYSE:WAT) to announce earnings per share of $1.54 for the current fiscal quarter, Zacks reports. Eight analysts have made estimates for Waters’ earnings. The highest EPS estimate is $1.57 and the lowest is $1.52. Waters posted earnings of $1.46 per share in the same quarter last year, which indicates a positive year over year growth rate of 5.5%. The firm is scheduled to report its next earnings results on Tuesday, April 24th.
On average, analysts expect that Waters will report full year earnings of $8.16 per share for the current year, with EPS estimates ranging from $8.10 to $8.23. For the next year, analysts anticipate that the business will report earnings of $8.96 per share, with EPS estimates ranging from $8.80 to $9.08. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of research analysts that that provide coverage for Waters.
Waters (NYSE:WAT) last issued its earnings results on Tuesday, January 23rd. The medical instruments supplier reported $2.51 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.44 by $0.07. Waters had a net margin of 0.88% and a return on equity of 24.70%. The firm had revenue of $687.28 million during the quarter, compared to analyst estimates of $671.98 million. During the same quarter in the prior year, the business earned $2.21 earnings per share. Waters’s revenue for the quarter was up 9.3% on a year-over-year basis.
WAT has been the topic of several recent analyst reports. Cowen reaffirmed a “hold” rating and issued a $190.00 price target on shares of Waters in a research note on Friday, November 3rd. Morgan Stanley raised shares of Waters from an “underweight” rating to an “equal weight” rating and set a $192.00 price target on the stock in a research note on Monday, December 4th. Zacks Investment Research downgraded shares of Waters from a “buy” rating to a “hold” rating in a research note on Thursday, October 26th. Deutsche Bank raised their price target on shares of Waters from $199.00 to $200.00 and gave the stock a “hold” rating in a research note on Wednesday, October 25th. Finally, BTIG Research began coverage on shares of Waters in a research note on Friday, January 5th. They issued a “buy” rating and a $230.00 price target on the stock. Twelve equities research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the stock. The stock has a consensus rating of “Hold” and an average price target of $203.75.
Shares of Waters (WAT) opened at $206.18 on Monday. Waters has a 12 month low of $152.05 and a 12 month high of $220.20. The firm has a market cap of $16,398.11, a price-to-earnings ratio of 1,085.22, a PEG ratio of 2.47 and a beta of 0.88. The company has a quick ratio of 1.97, a current ratio of 2.10 and a debt-to-equity ratio of 0.66.
In other Waters news, SVP Mark T. Beaudouin sold 42,143 shares of the firm’s stock in a transaction that occurred on Thursday, January 25th. The shares were sold at an average price of $217.21, for a total transaction of $9,153,881.03. Following the completion of the transaction, the senior vice president now directly owns 20,749 shares of the company’s stock, valued at approximately $4,506,890.29. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Elizabeth B. Rae sold 28,400 shares of the firm’s stock in a transaction that occurred on Monday, January 29th. The stock was sold at an average price of $219.01, for a total transaction of $6,219,884.00. Following the transaction, the senior vice president now directly owns 13,443 shares of the company’s stock, valued at $2,944,151.43. The disclosure for this sale can be found here. Insiders sold a total of 121,289 shares of company stock valued at $25,383,542 over the last quarter. 5.07% of the stock is owned by company insiders.
A number of institutional investors and hedge funds have recently bought and sold shares of the business. BlackRock Inc. increased its holdings in shares of Waters by 1.1% during the 4th quarter. BlackRock Inc. now owns 5,611,395 shares of the medical instruments supplier’s stock valued at $1,084,065,000 after purchasing an additional 60,000 shares in the last quarter. Harding Loevner LP increased its holdings in shares of Waters by 207.1% during the 3rd quarter. Harding Loevner LP now owns 2,768,174 shares of the medical instruments supplier’s stock valued at $158,275,000 after purchasing an additional 1,866,848 shares in the last quarter. Janus Henderson Group PLC increased its holdings in shares of Waters by 1.6% during the 3rd quarter. Janus Henderson Group PLC now owns 1,959,850 shares of the medical instruments supplier’s stock valued at $351,832,000 after purchasing an additional 30,057 shares in the last quarter. Renaissance Technologies LLC increased its holdings in shares of Waters by 59.1% during the 4th quarter. Renaissance Technologies LLC now owns 1,429,049 shares of the medical instruments supplier’s stock valued at $276,078,000 after purchasing an additional 530,949 shares in the last quarter. Finally, Geode Capital Management LLC increased its holdings in shares of Waters by 3.1% during the 4th quarter. Geode Capital Management LLC now owns 904,436 shares of the medical instruments supplier’s stock valued at $174,391,000 after purchasing an additional 27,215 shares in the last quarter. 91.58% of the stock is owned by institutional investors.
TRADEMARK VIOLATION WARNING: “Waters Co. (WAT) Expected to Announce Earnings of $1.54 Per Share” was originally posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this article on another site, it was copied illegally and republished in violation of U.S. & international copyright legislation. The original version of this article can be viewed at https://www.dispatchtribunal.com/2018/02/19/waters-co-wat-expected-to-announce-earnings-of-1-54-per-share.html.
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.
Get a free copy of the Zacks research report on Waters (WAT)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.